01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology
01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology
01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Boulikas</strong>: An overview on gene <strong>therapy</strong><br />
Figure 1. Role of E1A and E1B19-kDa proteins of adenovirus in apoptosis.<br />
penetration of the adenoviral particles by acid-catalyzed<br />
rupture of the endosomal membrane involving the penton<br />
protein and the integrins and allowing escape to the<br />
cytoplasmic compartment; a decrease in endosome pH<br />
during internalization expose hydrophobic domains of<br />
these adenoviral capsid proteins which permits these<br />
proteins to insert into the vesicle membrane in a fashion<br />
that ultimately disrupts its integrity (Seth et al, 1984). At<br />
the final step the adenoviral particle is attached to the<br />
cytoplasmic side of pore complexes and the DNA is<br />
released to the interior of pore annuli entering the<br />
nucleoplasm.<br />
These highly ordered processes are accompanied by<br />
losses or protease degradation of specific proteins on the<br />
viral particles; the fibers and some of the penton base<br />
complexes on the adenovirus surface are already lost<br />
during the process of endocytosis; a viral protease,<br />
L3/p23, located inside the capsid at 10 copies per virion,<br />
plays a key role in the stepwise dismantling and in the<br />
weakening of the capsid structure culminating with the<br />
release of the adenovirus DNA by degrading of the viral<br />
capsid protein VI (Greber et al, 1996). The mechanism of<br />
disruption of endosomes by the adenoviral particles has<br />
been exploited to augment efficiency of transfection with<br />
transferrin-polylysine-DNA complexes (see fusogenic<br />
peptides and Curiel et al, 1991; Cotten et al, 1992; Wagner<br />
et al, 1992b; Cristiano et al, 1993; Morishita et al, 1993;<br />
Harries et al, 1993; Curiel, 1994).<br />
To overcome one of the major limitations to the<br />
clinical utility of adenoviruses which is the low efficiency<br />
of gene transfer achieved in vivo, Arcasoy et al (1997)<br />
found that the presence of the polycations polybrene,<br />
protamine, DEAE-dextran, and poly-L-lysine significantly<br />
increased the transfection efficiency in cell culture using<br />
the lacZ gene; because the polyanion heparin did not<br />
10<br />
significantly alter gene transfer efficiency, but completely<br />
abrogated the effects of polycations it supports the idea<br />
that the negative charges presented by membrane<br />
glycoproteins reduce the efficiency of adenovirusmediated<br />
gene transfer, an obstacle that can be overcome<br />
by polycations.<br />
D. Advantages and drawbacks of<br />
adenoviral vectors in gene delivery<br />
Adenoviruses possess a linear double-stranded genome<br />
which can be manipulated to accommodate up to 7.5 kb of<br />
DNA. Adenoviruses have the advantage of being able to<br />
infect nondividing cells. Other advantages are the rarity of<br />
recombination events between adenoviral vectors and the<br />
host chromosomes, the absence of induction of human<br />
malignancies by adenoviruses, and the relative safety of<br />
their use as vaccines (e.g. Ballay et al, 1985; Haj-Ahmad<br />
and Graham, 1986). For safety, replication-deficient,<br />
infectious adenoviruses are being used in somatic gene<br />
transfer; for example deletion in a portion of the E3 region<br />
of the virus permits encapsidation whereas deletion of a<br />
portion of the E1A coding sequence impairs viral<br />
replication (Gilardi et al, 1990; Rosenfeld et al, 1991).<br />
E. Deletion of adenoviral DNA sequences<br />
for gene delivery<br />
First generation recombinant adenoviruses were<br />
rendered defective by deletion of sequences spanning the<br />
E1A and E1B genes; these adenoviruses expressed low<br />
levels of early and late viral genes responsible for<br />
activating destructive cellular immune responses. Further<br />
deletion of other essential genes and growth in new<br />
packaging cell lines or incorporation of temperature